Yungjin Pharm영진약품

Yungjin Pharm003520· Biotech & PharmaInitiation

Yungjin Pharm: Flat Revenue, Return to Losses and a Share Price Down 48.4% Over a Year

Yungjin Pharm's trailing revenue is about ₩253.0B, but the company swung to an operating loss of ₩4.3B in the 12 months to H1 2026 after small profits in prior years. The shares closed at ₩1,013, down 48.4% over one year and close to the 52-week low of ₩978.

Oct 21, 20260 views